|
Gene ontology annotations for HSP90AA1 |
|
|
Experiment description of studies that identified HSP90AA1 in sEVs |
| 1 |
| Experiment ID |
11 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
HSC70|HSP90|MHCII|CD63|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry [MALDI TOF]
|
| PubMed ID |
12519789
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. |
| Authors |
"Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W" |
| Journal name |
JBC
|
| Publication year |
2003 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15+) |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
1.15 g/mL
|
| Molecules identified in the study |
Protein Lipids |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Mass spectrometry [QTOF] Western blotting Thin layer chromatography HPLC |
|
|
| 2 |
| Experiment ID |
79 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
| 3 |
| Experiment ID |
80 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
| 4 |
| Experiment ID |
81 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
| 5 |
| Experiment ID |
76 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry Western blotting
|
| PubMed ID |
20224111
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomics analysis of bladder cancer exosomes. |
| Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
| Journal name |
MCP
|
| Publication year |
2010 |
| Sample |
Bladder cancer cells |
| Sample name |
HT1376 |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
1.10-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
| 6 |
| Experiment ID |
489 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 6 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 7 |
| Experiment ID |
490 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 7 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 8 |
| Experiment ID |
491 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 8 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 9 |
| Experiment ID |
492 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 9 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 10 |
| Experiment ID |
412 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MCF7 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 11 |
| Experiment ID |
414 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 12 |
| Experiment ID |
426 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD81|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Exo-rich fractions 7-10 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Size exclusion chromatography |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 13 |
| Experiment ID |
427 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|SDCBP|FLOT1|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Exo-rich fractions 1-6 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 14 |
| Experiment ID |
1206 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry ELISA |
|
|
| 15 |
| Experiment ID |
1223 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
31054213
|
| Organism |
Homo sapiens |
| Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
| Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
| Journal name |
Proteomics
|
| Publication year |
2019 |
| Sample |
Cholangiocarcinoma cells |
| Sample name |
KKU-M213 - in-gel digestion |
| Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 16 |
| Experiment ID |
1224 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
31054213
|
| Organism |
Homo sapiens |
| Experiment description |
Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma |
| Authors |
"Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C." |
| Journal name |
Proteomics
|
| Publication year |
2019 |
| Sample |
Cholangiocarcinoma cells |
| Sample name |
KKU-M213D5 - in-gel digestion |
| Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 17 |
| Experiment ID |
494 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
Osteoarthritic cartilage |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 18 |
| Experiment ID |
496 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
Healthy cartilage |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 19 |
| Experiment ID |
497 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
T/C-28a2 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 20 |
| Experiment ID |
498 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
T/C-28a2 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 21 |
| Experiment ID |
20 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
|
✔
GOLGA2|cytochrome c
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry Western blotting
|
| PubMed ID |
17956143
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
| Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
| Journal name |
JPR
|
| Publication year |
2007 |
| Sample |
Colorectal cancer cells |
| Sample name |
HT29 |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient Diafiltration |
| Flotation density |
1.16 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
| 22 |
| Experiment ID |
21 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
19837982
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
| Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
| Journal name |
MCP
|
| Publication year |
2009 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1215 |
| Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.10-1.12 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [Orbitrap] Western blotting |
|
|
| 23 |
| Experiment ID |
201 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22740476
|
| Organism |
Homo sapiens |
| Experiment description |
Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4. |
| Authors |
"Lim JW, Mathias RA, Kapp EA, Layton MJ, Faux MC, Burgess AW, Ji H, Simpson RJ." |
| Journal name |
Electrophoresis
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
SW480 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 24 |
| Experiment ID |
207 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DKO-1 |
| Isolation/purification methods |
Differential centrifugation Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 25 |
| Experiment ID |
208 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
Dks-8 |
| Isolation/purification methods |
Differential centrifugation Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 26 |
| Experiment ID |
209 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DLD-1 |
| Isolation/purification methods |
Differential centrifugation Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 27 |
| Experiment ID |
282 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Ultracentrifugation - Rep 1 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Western blotting |
|
|
| 28 |
| Experiment ID |
283 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Ultracentrifugation - Rep 2 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Western blotting |
|
|
| 29 |
| Experiment ID |
285 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Sequential centrifugal ultrafiltration - Rep 1 |
| Isolation/purification methods |
Differential centrifugation Filtration Sequential centrifugal ultrafiltration Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Western blotting |
|
|
| 30 |
| Experiment ID |
286 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Sequential centrifugal ultrafiltration - Rep 2 |
| Isolation/purification methods |
Differential centrifugation Filtration Sequential centrifugal ultrafiltration Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Western blotting |
|
|
| 31 |
| Experiment ID |
1203 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Colorectal cancer cells |
| Sample name |
DiFi |
| Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein miRNA |
| Methods used in the study |
Western blotting Mass spectrometry RNA sequencing |
|
|
| 32 |
| Experiment ID |
1361 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
TSG101|CD63|FLOT1|LAMP1|CD24|EPCAM|Alix
|
Enriched markers |
|
✔
HSP90AA1
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36303008
|
| Organism |
Homo sapiens |
| Experiment description |
A hydrogel-based mechanical metamaterial for the interferometric profiling of extracellular vesicles in patient samples |
| Authors |
"Zhao H, Pan S, Natalia A, Wu X, Ong CJ, Teo MCC, So JBY, Shao H." |
| Journal name |
Nat Biomed Eng
|
| Publication year |
2023 |
| Sample |
Colorectal cancer cells |
| Sample name |
HCT116 |
| Isolation/purification methods |
Filtration Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting MORPH ELISA |
|
|
| 33 |
| Experiment ID |
407 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD63|CD81|SDCBP|TSG101|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 34 |
| Experiment ID |
419 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD81|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T - Exo-rich fractions 7-10 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Size exclusion chromatography |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 35 |
| Experiment ID |
419 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD81|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T - Exo-rich fractions 7-10 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Size exclusion chromatography |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 36 |
| Experiment ID |
420 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|SDCBP|FLOT1|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T - Exo-rich fractions 1-6 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 37 |
| Experiment ID |
420 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|SDCBP|FLOT1|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T - Exo-rich fractions 1-6 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 38 |
| Experiment ID |
513 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36214496
|
| Organism |
Homo sapiens |
| Experiment description |
Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA |
| Authors |
"McCann J, Sosa-Miranda CD, Guo H, Reshke R, Savard A, Zardini Buzatto A, Taylor JA, Li L, Gibbings DJ." |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293 - fraction 1-2 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 39 |
| Experiment ID |
514 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9|FLOT2
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36214496
|
| Organism |
Homo sapiens |
| Experiment description |
Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA |
| Authors |
"McCann J, Sosa-Miranda CD, Guo H, Reshke R, Savard A, Zardini Buzatto A, Taylor JA, Li L, Gibbings DJ." |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293 - fraction 3-4 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 40 |
| Experiment ID |
1275 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9|TSG101|FLOT1|FLOT2|RAB35|RAB5A|GAPDH|TFRC|CD63|Alix
|
Enriched markers |
|
✔
PCNA|CANX|GAPDH|HSP90AA1|HSP90B1
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36706192
|
| Organism |
Homo sapiens |
| Experiment description |
Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles |
| Authors |
"Choi S, Yang Z, Wang Q, Qiao Z, Sun M, Wiggins J, Xiang SH, Lu Q." |
| Journal name |
Sci Adv
|
| Publication year |
2023 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 41 |
| Experiment ID |
1280 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
TSG101|CD9|FLOT1|FLOT2|RAB35|RAB5A|GAPDH|TFRC|CD63|Alix
|
Enriched markers |
|
✔
PCNA|CANX|GAPDH|HSP90AA1|HSP90B1
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36706192
|
| Organism |
Homo sapiens |
| Experiment description |
Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles |
| Authors |
"Choi S, Yang Z, Wang Q, Qiao Z, Sun M, Wiggins J, Xiang SH, Lu Q." |
| Journal name |
Sci Adv
|
| Publication year |
2023 |
| Sample |
Embryonic kidney cells |
| Sample name |
HEK293T - Fraction 5 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
1.151 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 42 |
| Experiment ID |
405 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD63|CD81|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Foreskin fibroblasts |
| Sample name |
BJ |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 43 |
| Experiment ID |
363 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 44 |
| Experiment ID |
364 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 45 |
| Experiment ID |
365 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 46 |
| Experiment ID |
236 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
mRNA
|
| Identification method |
RNA Sequencing
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
MHCC97L |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein RNA |
| Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
| 47 |
| Experiment ID |
4 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
CD63|MHCI|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
11487543
|
| Organism |
Homo sapiens |
| Experiment description |
Intestinal epithelial cells secrete exosome-like vesicles. |
| Authors |
"van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M" |
| Journal name |
Not applicable
|
| Publication year |
2001 |
| Sample |
Intestinal epithelial cells |
| Sample name |
HT29-19A T84-DRB1*0401/CIITA |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
| 48 |
| Experiment ID |
1324 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
GAPDH|CD63|LAMP1|FLOT1|TSG101|Alix
|
Enriched markers |
|
✔
GAPDH|HSP90AA1
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33686255
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy. |
| Authors |
"Pan S, Zhang Y, Natalia A, Lim CZJ, Ho NRY, Chowbay B, Loh TP, Tam JKC, Shao H." |
| Journal name |
Nat Nanotechnol
|
| Publication year |
2021 |
| Sample |
Lung cancer cells |
| Sample name |
H3255 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 49 |
| Experiment ID |
740 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung epithelial cells |
| Sample name |
BEAS-2B |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 50 |
| Experiment ID |
741 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung epithelial cells |
| Sample name |
BEAS-2B |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 51 |
| Experiment ID |
742 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP
|
Enriched markers |
|
✔
TUBA1A
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
35136055
|
| Organism |
Homo sapiens |
| Experiment description |
"Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells" |
| Authors |
"Kim O, Hwangbo C, Tran PT, Lee JH." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Lung epithelial cells |
| Sample name |
BEAS-2B |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 52 |
| Experiment ID |
417 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD63|SDCBP|LAMP1|CD9|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Lymphoma cells |
| Sample name |
Raji |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 53 |
| Experiment ID |
51 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Breast cancer |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
| 54 |
| Experiment ID |
52 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Lung cancer |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
| 55 |
| Experiment ID |
53 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Mesothelioma |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
| 56 |
| Experiment ID |
54 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Ovarian adenocarcioma |
| Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 57 |
| Experiment ID |
411 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Mammary cancer-associated fibroblasts |
| Sample name |
mCAF |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 58 |
| Experiment ID |
200 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|TSG101|Alix|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22635005
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. |
| Authors |
"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D." |
| Journal name |
Nat Med
|
| Publication year |
2012 |
| Sample |
Melanoma cells |
| Sample name |
B16-F10 SK-MEL-202 SK-MEL035 SK-MEL-265 |
| Isolation/purification methods |
Differential centrifugation Filtration Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 59 |
| Experiment ID |
254 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
MNT-1 |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 60 |
| Experiment ID |
255 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
G1 |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 61 |
| Experiment ID |
256 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
501mel |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 62 |
| Experiment ID |
257 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
Daju |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 63 |
| Experiment ID |
258 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
SKMEL28 |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 64 |
| Experiment ID |
259 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
A375M |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 65 |
| Experiment ID |
260 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
1205Lu |
| Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 66 |
| Experiment ID |
1107 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD81|GAPDH
|
Enriched markers |
|
✔
GOLGA2|CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34957415
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism |
| Authors |
"GarcÃa-Silva S, Benito-MartÃn A, Nogués L, Hernández-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Ximénez-Embún P, Kataru RP, Lopez AA, Merino C, Sánchez-Redondo S, Graña-Castro O, Matei I, Nicolás-Avila JÃ, Torres-Ruiz R, RodrÃguez-Perales S, MartÃnez L, Pérez-MartÃnez M, Mata G, Szumera-Ciećkiewicz A, Kalinowska I, Saltari A, MartÃnez-Gómez JM, Hogan SA, Saragovi HU, Ortega S, Garcia-Martin C, Boskovic J, Levesque MP, Rutkowski P, Hidalgo A, Muñoz J, MegÃas D, Mehrara BJ, Lyden D, Peinado H." |
| Journal name |
Nat Cancer
|
| Publication year |
2021 |
| Sample |
Melanoma cells |
| Sample name |
SK-MEL-147 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Flow cytometry |
|
|
| 67 |
| Experiment ID |
126 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
| PubMed ID |
Unpublished / Not applicable
|
| Organism |
Homo sapiens |
| Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
| Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
| Journal name |
Mesenchymal Stem Cell Therapy
|
| Publication year |
2011 |
| Sample |
Mesenchymal stem cells |
| Sample name |
huES9.E1 |
| Isolation/purification methods |
HPLC |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
| 68 |
| Experiment ID |
488 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Mesenchymal stem cells |
| Sample name |
UCMSC |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectometry |
|
|
| 69 |
| Experiment ID |
25 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
HSP90|beta-tubulin
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting Mass spectrometry
|
| PubMed ID |
15111327
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes secreted by human mesothelioma cells. |
| Authors |
"Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN." |
| Journal name |
AJP
|
| Publication year |
2004 |
| Sample |
Mesothelioma cells |
| Sample name |
PMR-MM7 PMR-MM8 |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
| 70 |
| Experiment ID |
418 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Monocytic leukemia cells |
| Sample name |
THP-1 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 71 |
| Experiment ID |
219 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25857718
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins |
| Authors |
"Chan YK, Zhang H, Liu P, Tsao GS, Li Lung M, Mak NK, Ngok-Shun Wong R, Ying-Kit Yue P" |
| Journal name |
Int J Cancer
|
| Publication year |
2015 |
| Sample |
Nasopharyngeal carcinoma cells |
| Sample name |
C666-1 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.17-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 72 |
| Experiment ID |
220 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25857718
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins |
| Authors |
"Chan YK, Zhang H, Liu P, Tsao GS, Li Lung M, Mak NK, Ngok-Shun Wong R, Ying-Kit Yue P" |
| Journal name |
Int J Cancer
|
| Publication year |
2015 |
| Sample |
Nasopharyngeal carcinoma cells |
| Sample name |
NP69 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.17-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 73 |
| Experiment ID |
221 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25857718
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins |
| Authors |
"Chan YK, Zhang H, Liu P, Tsao GS, Li Lung M, Mak NK, Ngok-Shun Wong R, Ying-Kit Yue P" |
| Journal name |
Int J Cancer
|
| Publication year |
2015 |
| Sample |
Nasopharyngeal carcinoma cells |
| Sample name |
NP460 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.17-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 74 |
| Experiment ID |
224 |
| MISEV standards |
|
✔
EM|AFM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25944692
|
| Organism |
Homo sapiens |
| Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
| Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Neuroblastoma cells |
| Sample name |
SH-SY5Y |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
| Flotation density |
1.10 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Western blotting |
|
|
| 75 |
| Experiment ID |
413 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Normal mammary epithelial cells |
| Sample name |
MCF10A |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 76 |
| Experiment ID |
211 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
cytochrome c|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
IGROV1 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 77 |
| Experiment ID |
212 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
Cytochrome C|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
OVCAR-3 |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 78 |
| Experiment ID |
406 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35|CD81
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic cancer cells |
| Sample name |
BxPC3 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 79 |
| Experiment ID |
415 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic cancer cells |
| Sample name |
PANC-1 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 80 |
| Experiment ID |
434 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD81|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic cancer cells |
| Sample name |
PANC-1 - Exo-rich fractions 7-10 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Size exclusion chromatography |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 81 |
| Experiment ID |
435 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|SDCBP|FLOT1|CD9|CD151|FLOT2|TSG101|LAMP1|TFRC|RAB5A|RAB35|GAPDH|UCHL1|ICAM1
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic cancer cells |
| Sample name |
PANC-1 - Exo-rich fractions 1-6 pooled |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 82 |
| Experiment ID |
1205 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1|SDCBP
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic cancer cells |
| Sample name |
PANC-1 |
| Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 83 |
| Experiment ID |
408 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD63|CD81|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic duct epithalial cells |
| Sample name |
HPDE |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 84 |
| Experiment ID |
409 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD63|SDCBP|LAMP1|CD9|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic duct epithalial cells |
| Sample name |
HPNE |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 85 |
| Experiment ID |
519 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|TSG101
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36417505
|
| Organism |
Homo sapiens |
| Experiment description |
A solution to the biophysical fractionation of extracellular vesicles: Acoustic Nanoscale Separation via Wave-pillar Excitation Resonance (ANSWER) |
| Authors |
"Zhang J, Chen C, Becker R, Rufo J, Yang S, Mai J, Zhang P, Gu Y, Wang Z, Ma Z, Xia J, Hao N, Tian Z, Wong DTW, Sadovsky Y, Lee LP, Huang TJ." |
| Journal name |
Sci Adv
|
| Publication year |
2022 |
| Sample |
Plasma |
| Sample name |
Plasma |
| Isolation/purification methods |
Acoustic nanoscale separation via wave-pillar excitation resonance (ANSWER) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 86 |
| Experiment ID |
606 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|HSP90|TSG101|GAPDH
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36624553
|
| Organism |
Homo sapiens |
| Experiment description |
Combination of size-exclusion chromatography and ion exchange adsorption for improving the proteomic analysis of plasma-derived extracellular vesicles |
| Authors |
"Wang Y, Zhang Y, Li Z, Wei S, Chi X, Yan X, Lv H, Zhao L, Zhao L. " |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Plasma |
| Sample name |
Plasma - Ion exchange adsorption 12.5 mg |
| Isolation/purification methods |
Filtration Size exclusion chromatography Ion exchange adsorption Centrifugation Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 87 |
| Experiment ID |
607 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|HSP90|TSG101|GAPDH
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36624553
|
| Organism |
Homo sapiens |
| Experiment description |
Combination of size-exclusion chromatography and ion exchange adsorption for improving the proteomic analysis of plasma-derived extracellular vesicles |
| Authors |
"Wang Y, Zhang Y, Li Z, Wei S, Chi X, Yan X, Lv H, Zhao L, Zhao L. " |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Plasma |
| Sample name |
Plasma - Ion exchange adsorption 25 mg |
| Isolation/purification methods |
Filtration Size exclusion chromatography Ion exchange adsorption Centrifugation Centrifugal ultrafiltration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 88 |
| Experiment ID |
231 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
Alix|CD63|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 1 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein Lipids |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 89 |
| Experiment ID |
232 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 2 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 90 |
| Experiment ID |
233 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 3 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 91 |
| Experiment ID |
416 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pluripotent stem cells |
| Sample name |
PSC |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 92 |
| Experiment ID |
138 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 93 |
| Experiment ID |
139 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 94 |
| Experiment ID |
140 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
VCaP - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 95 |
| Experiment ID |
141 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
VCaP - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 96 |
| Experiment ID |
145 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
C4-2 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 97 |
| Experiment ID |
275 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
|
✔
AIF
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25844599
|
| Organism |
Homo sapiens |
| Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
| Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Docetaxel sensitive |
| Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.12-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
| 98 |
| Experiment ID |
274 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
|
✔
AIF
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25844599
|
| Organism |
Homo sapiens |
| Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
| Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Docetaxel resistant |
| Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
| Flotation density |
1.13-1.18 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
| 99 |
| Experiment ID |
834 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35333565
|
| Organism |
Homo sapiens |
| Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
| Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
| Journal name |
Sci Adv
|
| Publication year |
2022 |
| Sample |
Retinal pigment epithelial cells |
| Sample name |
ARPE-19 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 100 |
| Experiment ID |
835 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35333565
|
| Organism |
Homo sapiens |
| Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
| Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
| Journal name |
Sci Adv
|
| Publication year |
2022 |
| Sample |
Retinal pigment epithelial cells |
| Sample name |
ARPE-19 |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting Mass spectrometry |
|
|
| 101 |
| Experiment ID |
66 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19199708
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
| Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
| Journal name |
JPR
|
| Publication year |
2009 |
| Sample |
Saliva |
| Sample name |
Saliva |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
| 102 |
| Experiment ID |
410 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD63|SDCBP|LAMP1|CD9|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
T lymphocytes |
| Sample name |
Jurkat |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein mRNA |
| Methods used in the study |
RT-qPCR Western blotting Mass spectrometry Flow cytometry |
|
|
| 103 |
| Experiment ID |
217 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23844026
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of human thymic exosomes. |
| Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
| Journal name |
PLoS One
|
| Publication year |
2013 |
| Sample |
Thymus |
| Sample name |
Normal-Thymus |
| Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 104 |
| Experiment ID |
13 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
Alix|RAB4|RAB5B|RAB11|TSG101|CD9|AQP2|AQP1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15326289
|
| Organism |
Homo sapiens |
| Experiment description |
Identification and proteomic profiling of exosomes in human urine. |
| Authors |
"Pisitkun T, Shen RF, Knepper MA" |
| Journal name |
PNAS
|
| Publication year |
2004 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LCQ DECA XP] Western blotting |
|
|
| 105 |
| Experiment ID |
193 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
PHB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 106 |
| Experiment ID |
194 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of basement membrane nephropathy |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 107 |
| Experiment ID |
195 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of early IgA nephropathy |
| Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 108 |
| Experiment ID |
196 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal high density |
| Isolation/purification methods |
Differential centrifugation Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 109 |
| Experiment ID |
197 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal low density |
| Isolation/purification methods |
Differential centrifugation Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for HSP90AA1 |
| |
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
| 1 |
REV1 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 2 |
ITGB1 |
3688 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 3 |
SPATS2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 4 |
AXL |
558 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 5 |
SLC25A13 |
10165 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 6 |
CCAR2 |
57805 |
| Co-fractionation |
 |
Homo sapiens |
|
| 7 |
ISG15 |
9636 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 8 |
PRDM1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 9 |
MARK2 |
2011 |
| Co-fractionation |
 |
Homo sapiens |
|
| 10 |
UBL4A |
8266 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 11 |
GSTP1 |
2950 |
| Co-fractionation |
 |
Homo sapiens |
|
| 12 |
TSSK2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 13 |
SHC1 |
6464 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 14 |
MATK |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 15 |
MIS12 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 16 |
MYLK4 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 17 |
PRPF8 |
10594 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 18 |
LLGL1 |
3996 |
| Synthetic Lethality |
 |
Homo sapiens |
|
| 19 |
RIN3 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 20 |
CSNK1A1 |
1452 |
| Biochemical Activity |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 21 |
HNRNPK |
3190 |
| Co-fractionation |
 |
Homo sapiens |
|
| 22 |
CAP1 |
10487 |
| Co-fractionation |
 |
Homo sapiens |
|
| 23 |
WDR87 |
|
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 24 |
Stub1 |
56424 |
| Affinity Capture-Western |
 |
Mus musculus |
| Co-crystal Structure |
 |
Mus musculus |
|
| 25 |
UBA1 |
7317 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 26 |
BRCA1 |
672 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 27 |
NLRP12 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 28 |
RPL17 |
6139 |
| Co-fractionation |
 |
Homo sapiens |
|
| 29 |
PRKAA2 |
5563 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 30 |
AKT3 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 31 |
CSNK2A1 |
1457 |
| Biochemical Activity |
 |
Homo sapiens |
| Biochemical Activity |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 32 |
VHL |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Negative Genetic |
 |
Homo sapiens |
|
| 33 |
MID1 |
4281 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 34 |
RIPK1 |
8737 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 35 |
HDAC4 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 36 |
PRKDC |
5591 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 37 |
PMF1 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 38 |
TRAF2 |
7186 |
| Co-fractionation |
 |
Homo sapiens |
|
| 39 |
FGFR3 |
2261 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 40 |
DAPK3 |
1613 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 41 |
POLH |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 42 |
MAP3K5 |
4217 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 43 |
IGF2BP3 |
10643 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 44 |
WDR76 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 45 |
DTX3 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 46 |
SKIV2L2 |
23517 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 47 |
NOD1 |
10392 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 48 |
IARS2 |
55699 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 49 |
NDRG1 |
10397 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 50 |
PPP6C |
5537 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 51 |
BRMS1 |
25855 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 52 |
METTL22 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 53 |
GRK4 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 54 |
SMYD3 |
64754 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 55 |
CALD1 |
800 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 56 |
SRC |
6714 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 57 |
HSPH1 |
10808 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 58 |
RCBTB2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 59 |
HIPK4 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 60 |
MARCH5 |
|
| Proximity Label-MS |
 |
Homo sapiens |
|
| 61 |
PIK3C3 |
5289 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 62 |
NR3C1 |
2908 |
| Co-localization |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 63 |
MAGED2 |
10916 |
| Co-fractionation |
 |
Homo sapiens |
|
| 64 |
FBXL13 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 65 |
CHORDC1 |
26973 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 66 |
TXNDC5 |
81567 |
| Co-fractionation |
 |
Homo sapiens |
|
| 67 |
RPS6KC1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 68 |
SYDE2 |
|
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 69 |
METTL18 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 70 |
PPP6R3 |
55291 |
| Co-fractionation |
 |
Homo sapiens |
|
| 71 |
AIMP2 |
7965 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 72 |
WDR5 |
11091 |
| Co-fractionation |
 |
Homo sapiens |
|
| 73 |
FKBPL |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 74 |
LSM1 |
27257 |
| Two-hybrid |
 |
Homo sapiens |
|
| 75 |
NEIL3 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 76 |
KLHL25 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 77 |
CDKN1B |
1027 |
| Synthetic Lethality |
 |
Homo sapiens |
|
| 78 |
DYRK4 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 79 |
AGO2 |
27161 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 80 |
UNK |
|
| Affinity Capture-RNA |
 |
Homo sapiens |
|
| 81 |
AARS |
16 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 82 |
CHMP4C |
92421 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 83 |
AURKA |
6790 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 84 |
Dnajc7 |
56354 |
| Affinity Capture-Western |
 |
Mus musculus |
|
| 85 |
HSP90AB4P |
664618 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 86 |
YTHDC2 |
64848 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 87 |
Tgfbr2 |
|
| Affinity Capture-Western |
 |
Rattus norvegicus |
|
| 88 |
PKM |
5315 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 89 |
TRIM7 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 90 |
MAP3K2 |
10746 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 91 |
RHOBTB2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
|
| 92 |
USP11 |
8237 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 93 |
PDRG1 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 94 |
PDGFRB |
5159 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 95 |
KLHL34 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 96 |
SUPT5H |
6829 |
| Co-fractionation |
 |
Homo sapiens |
|
| 97 |
DNAJA2 |
10294 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 98 |
SIM2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 99 |
TUFM |
7284 |
| Co-fractionation |
 |
Homo sapiens |
|
| 100 |
PRKCG |
5582 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 101 |
CERS2 |
29956 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 102 |
TUBB2B |
347733 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 103 |
UBASH3B |
84959 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 104 |
ESRRB |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
|
| 105 |
NTRK3 |
4916 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 106 |
CDH1 |
999 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 107 |
HERC6 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 108 |
FYN |
2534 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 109 |
NUDC |
10726 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 110 |
MYH9 |
4627 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 111 |
TYK2 |
7297 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 112 |
TRIM21 |
6737 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 113 |
OGT |
8473 |
| Reconstituted Complex |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 114 |
PTGDR |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 115 |
RGS11 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 116 |
HLA-DRB5 |
3127 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 117 |
CDK5R1 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 118 |
NOS2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 119 |
P4HB |
5034 |
| Co-fractionation |
 |
Homo sapiens |
|
| 120 |
ENO1 |
2023 |
| Co-fractionation |
 |
Homo sapiens |
|
| 121 |
CUL2 |
8453 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 122 |
SRPK3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 123 |
EBNA-LP |
|
| Affinity Capture-Western |
 |
|
|
| 124 |
SND1 |
27044 |
| Co-fractionation |
 |
Homo sapiens |
|
| 125 |
Nos1 |
|
| Affinity Capture-Western |
 |
Rattus norvegicus |
|
| 126 |
VPS18 |
57617 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 127 |
SRPK1 |
6732 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 128 |
SGK3 |
23678 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 129 |
SLC25A5 |
292 |
| Co-fractionation |
 |
Homo sapiens |
|
| 130 |
MGMT |
4255 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 131 |
DSN1 |
79980 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 132 |
SSR4 |
6748 |
| Co-fractionation |
 |
Homo sapiens |
|
| 133 |
MAP4K2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 134 |
ARMC5 |
79798 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 135 |
HK2 |
3099 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 136 |
NUAK2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 137 |
TMPO |
7112 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 138 |
BRF1 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 139 |
NES |
10763 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 140 |
TYMP |
1890 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 141 |
DAP3 |
7818 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 142 |
AHCYL1 |
10768 |
| Co-fractionation |
 |
Homo sapiens |
|
| 143 |
C20orf194 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 144 |
PLA2G4A |
5321 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 145 |
SUGT1 |
10910 |
| Reconstituted Complex |
 |
Homo sapiens |
| Co-crystal Structure |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 146 |
SGK1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 147 |
EPAS1 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 148 |
IQCB1 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 149 |
TSSK3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 150 |
TBC1D10B |
26000 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 151 |
TUBAL3 |
79861 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 152 |
PRKCZ |
5590 |
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 153 |
MAP4K4 |
9448 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 154 |
CUL3 |
8452 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 155 |
PAK6 |
56924 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 156 |
MYLK3 |
91807 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 157 |
MAP2K5 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 158 |
FKBP8 |
23770 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 159 |
SH3RF2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 160 |
EPRS |
2058 |
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Co-purification |
 |
Homo sapiens |
|
| 161 |
PI4K2A |
55361 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 162 |
GZMA |
3001 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 163 |
RBBP4 |
5928 |
| Co-fractionation |
 |
Homo sapiens |
|
| 164 |
NPAS2 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 165 |
FN1 |
2335 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 166 |
GUCY2D |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 167 |
MECP2 |
4204 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 168 |
BLK |
640 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 169 |
PRMT5 |
10419 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 170 |
FANCA |
|
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 171 |
PI4K2B |
55300 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 172 |
PCBP1 |
5093 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 173 |
PSMD10 |
5716 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 174 |
RPA3 |
6119 |
| Proximity Label-MS |
 |
Homo sapiens |
|
| 175 |
AHR |
196 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 176 |
PSKH2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 177 |
SHKBP1 |
|
| Protein-RNA |
 |
Homo sapiens |
|
| 178 |
HSPA1A |
3303 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 179 |
HSPA4 |
3308 |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 180 |
PREB |
10113 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 181 |
RFWD3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 182 |
SGTA |
6449 |
| Far Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 183 |
LY6E |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 184 |
DLX6 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 185 |
AKT1 |
207 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 186 |
GRK7 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 187 |
Lrr1 |
|
| Affinity Capture-MS |
 |
Mus musculus |
|
| 188 |
CAMK2G |
818 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 189 |
TGFBR2 |
7048 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 190 |
DDX55 |
|
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 191 |
KCNA5 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 192 |
RPS16 |
6217 |
| Co-fractionation |
 |
Homo sapiens |
|
| 193 |
STUB1 |
10273 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Biochemical Activity |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Biochemical Activity |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Biochemical Activity |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Biochemical Activity |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Protein-peptide |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 194 |
EPHB6 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 195 |
DDX46 |
9879 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 196 |
PAFAH1B1 |
5048 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 197 |
HSPE1 |
3336 |
| Co-fractionation |
 |
Homo sapiens |
|
| 198 |
GRK5 |
2869 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 199 |
ASB3 |
51130 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 200 |
FASN |
2194 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 201 |
SUDS3 |
|
| Co-fractionation |
 |
Homo sapiens |
|
| 202 |
NDUFAF2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 203 |
GRB2 |
2885 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 204 |
RHOBTB3 |
22836 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 205 |
RNF40 |
9810 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 206 |
PSAT1 |
29968 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 207 |
FBXO10 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 208 |
RUVBL2 |
10856 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 209 |
TXLNA |
200081 |
| Co-fractionation |
 |
Homo sapiens |
|
| 210 |
RAB40A |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 211 |
LRPPRC |
10128 |
| Co-fractionation |
 |
Homo sapiens |
|
| 212 |
CDC37 |
11140 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-crystal Structure |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 213 |
TYRO3 |
7301 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 214 |
LCK |
3932 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 215 |
NR3C2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 216 |
CDK15 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 217 |
PRKCH |
5583 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 218 |
BMPR1A |
657 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 219 |
RET |
5979 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 220 |
TTK |
7272 |
| Biochemical Activity |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 221 |
HSP90AA1 |
3320 |
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 222 |
STK38L |
23012 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 223 |
SIRT1 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 224 |
RCBTB1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 225 |
HDAC8 |
55869 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 226 |
FLCN |
201163 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 227 |
NR1I2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 228 |
DYNC1H1 |
1778 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 229 |
TBK1 |
29110 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 230 |
NCL |
4691 |
| Co-fractionation |
 |
Homo sapiens |
|
| 231 |
BCL2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 232 |
PRKCA |
5578 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 233 |
CDK4 |
1019 |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 234 |
Cdc37 |
12539 |
| Affinity Capture-MS |
 |
Mus musculus |
|
| 235 |
CYLD |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 236 |
PCGF6 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 237 |
STK32B |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 238 |
YWHAZ |
7534 |
| Co-fractionation |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 239 |
FOXM1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 240 |
EPHA2 |
1969 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 241 |
TXNIP |
10628 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 242 |
PTGES3 |
10728 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| PCA |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 243 |
SNW1 |
22938 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 244 |
CAMK2D |
817 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 245 |
NFIC |
4782 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 246 |
DMRTA1 |
63951 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 247 |
NTRK2 |
4915 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 248 |
PRKG2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 249 |
RBCK1 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 250 |
RPS6KA6 |
27330 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 251 |
IL1B |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 252 |
EDRF1 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 253 |
YES1 |
7525 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 254 |
PABPN1 |
8106 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 255 |
ATR |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Synthetic Lethality |
 |
Homo sapiens |
|
| 256 |
HIF3A |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 257 |
LDHA |
3939 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 258 |
HSP90AB2P |
391634 |
| Co-fractionation |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 259 |
PRKAA1 |
5562 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 260 |
SKP1 |
6500 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 261 |
ISX |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 262 |
ERN1 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 263 |
SPRTN |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 264 |
Ppard |
|
| Affinity Capture-Western |
 |
Mus musculus |
|
| 265 |
CDK3 |
1018 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 266 |
HSPA6 |
3310 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 267 |
AIPL1 |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 268 |
MYLK2 |
85366 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 269 |
TARDBP |
23435 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 270 |
DAPK1 |
1612 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 271 |
BTF3 |
689 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 272 |
MCF2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 273 |
FASTK |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 274 |
UCHL1 |
7345 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 275 |
NUDCD3 |
23386 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 276 |
DYNC1I1 |
|
| Proximity Label-MS |
 |
Homo sapiens |
|
| 277 |
FBXL8 |
55336 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 278 |
HSP90AB1 |
3326 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 279 |
CAND1 |
55832 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 280 |
ACTN1 |
87 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 281 |
SYVN1 |
84447 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 282 |
FES |
2242 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 283 |
FNIP1 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 284 |
SETDB1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 285 |
RPS3 |
6188 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 286 |
DNAJB6 |
10049 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 287 |
TGFBR1 |
7046 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 288 |
LGALS3BP |
3959 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 289 |
PER2 |
|
| Proximity Label-MS |
 |
Homo sapiens |
|
| 290 |
XRCC1 |
7515 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 291 |
TRDN |
10345 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 292 |
PGK1 |
5230 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 293 |
TNK1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 294 |
NLRP4 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 295 |
DIAPH1 |
1729 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 296 |
PACRG |
135138 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 297 |
BTRC |
8945 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 298 |
HSPA2 |
3306 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 299 |
APAF1 |
317 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Protein-peptide |
 |
Homo sapiens |
|
| 300 |
ZNF74 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 301 |
CDK11B |
984 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 302 |
COPS6 |
10980 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 303 |
FZR1 |
|
| Synthetic Lethality |
 |
Homo sapiens |
|
| 304 |
FBXO17 |
115290 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 305 |
MAD2L2 |
10459 |
| Proximity Label-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 306 |
FER |
2241 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 307 |
FBXO28 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 308 |
TARS |
6897 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 309 |
STIP1 |
10963 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 310 |
HSPA7 |
3311 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 311 |
FANCD2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 312 |
DNAJC7 |
7266 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 313 |
VCAM1 |
7412 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 314 |
TOMM40 |
10452 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 315 |
LIMK1 |
3984 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 316 |
RPS6KA2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 317 |
CUL1 |
8454 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 318 |
SGK2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 319 |
FOXP2 |
93986 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 320 |
EIF4G1 |
1981 |
| Co-fractionation |
 |
Homo sapiens |
|
| 321 |
FGFR1 |
2260 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 322 |
GSK3B |
2932 |
| Biochemical Activity |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 323 |
LARP4B |
23185 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 324 |
RPS6KL1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 325 |
DYRK1B |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 326 |
PAK1 |
5058 |
| Two-hybrid |
 |
Homo sapiens |
|
| 327 |
CCT2 |
10576 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 328 |
KLHL26 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 329 |
CAMK2A |
815 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 330 |
FBXL3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 331 |
VRK3 |
51231 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 332 |
GUCY1A2 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 333 |
PPP5C |
5536 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Protein-peptide |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Proximity Label-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 334 |
TTC4 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 335 |
MCC |
4163 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 336 |
NFRKB |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 337 |
FBXO24 |
26261 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 338 |
CDKN1A |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 339 |
RPL4 |
6124 |
| Co-fractionation |
 |
Homo sapiens |
|
| 340 |
CDK5 |
1020 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 341 |
NR1H3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 342 |
Crnkl1 |
|
| Affinity Capture-Western |
 |
Mus musculus |
|
| 343 |
CAMK1G |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 344 |
LYN |
4067 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 345 |
MAP3K9 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 346 |
PSMD14 |
10213 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 347 |
SPSB3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 348 |
SNRNP200 |
23020 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 349 |
EPHA1 |
2041 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 350 |
RPS6KB1 |
6198 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 351 |
RAG1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 352 |
NELFE |
7936 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 353 |
KCNA6 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 354 |
SLC9A1 |
6548 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 355 |
PTK2B |
2185 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 356 |
TEAD2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 357 |
GAPDH |
2597 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Co-fractionation |
 |
Homo sapiens |
|
| 358 |
PKN1 |
5585 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 359 |
ZBTB49 |
166793 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 360 |
TTC9C |
283237 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 361 |
Bag2 |
|
| Affinity Capture-MS |
 |
Mus musculus |
|
| 362 |
BCL6 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 363 |
RPLP0 |
6175 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 364 |
TRIM17 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 365 |
SREBF1 |
6720 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 366 |
SKP2 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 367 |
Ksr1 |
|
| Affinity Capture-MS |
 |
Mus musculus |
| Affinity Capture-Western |
 |
Mus musculus |
| Affinity Capture-MS |
 |
Mus musculus |
|
| 368 |
RAD21 |
5885 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 369 |
G2E3 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 370 |
EIF4B |
1975 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 371 |
ASB6 |
140459 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 372 |
FBXL4 |
26235 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 373 |
MINK1 |
50488 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 374 |
LAT |
27040 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 375 |
DDR1 |
780 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 376 |
CAMKMT |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 377 |
ENC1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 378 |
PSMA3 |
5684 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 379 |
CANX |
821 |
| Co-fractionation |
 |
Homo sapiens |
|
| 380 |
NHLRC1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 381 |
TRIM49 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 382 |
XPO1 |
7514 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 383 |
RC3H2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 384 |
IKZF3 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 385 |
POLR2E |
5434 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 386 |
MEX3A |
|
| Affinity Capture-RNA |
 |
Homo sapiens |
|
| 387 |
PCGF1 |
84759 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 388 |
TJP1 |
7082 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 389 |
ATP5F1 |
515 |
| Co-fractionation |
 |
Homo sapiens |
|
| 390 |
TUBB4B |
10383 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 391 |
EGFR |
1956 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Two-hybrid |
 |
Homo sapiens |
| PCA |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 392 |
FBXL18 |
80028 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 393 |
GUCY1B3 |
|
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 394 |
MAFG |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 395 |
MAP3K8 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 396 |
HSP90AA5P |
730211 |
| Co-fractionation |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 397 |
IKZF1 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 398 |
CKS1B |
|
| Reconstituted Complex |
 |
Homo sapiens |
|
| 399 |
RIPK4 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 400 |
HIST3H3 |
8290 |
| Co-purification |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 401 |
SPTBN1 |
6711 |
| Co-fractionation |
 |
Homo sapiens |
|
| 402 |
PKN2 |
5586 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 403 |
Stk11 |
|
| Affinity Capture-MS |
 |
Mus musculus |
| Affinity Capture-Western |
 |
Mus musculus |
|
| 404 |
TOMM70A |
9868 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 405 |
EFTUD2 |
9343 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 406 |
HADHA |
3030 |
| Co-fractionation |
 |
Homo sapiens |
|
| 407 |
CDK2 |
1017 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 408 |
CEP250 |
11190 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 409 |
MAP2K3 |
5606 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 410 |
MAP4K1 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 411 |
TADA2A |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 412 |
PTK2 |
5747 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 413 |
PPP2R1A |
5518 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 414 |
UBASH3A |
53347 |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 415 |
NLRP3 |
|
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 416 |
SLC3A2 |
6520 |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 417 |
FUS |
2521 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 418 |
LARS |
51520 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 419 |
CSNK2A2 |
1459 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
|
| 420 |
CDKL4 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 421 |
MARCH9 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 422 |
LMLN |
|
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 423 |
MET |
4233 |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 424 |
HNRNPAB |
3182 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
|
| 425 |
RABGAP1 |
23637 |
| Co-fractionation |
 |
Homo sapiens |
|
| 426 |
RPL23A |
6147 |
| Co-fractionation |
 |
Homo sapiens |
|
| 427 |
DDRGK1 |
65992 |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 428 |
ZC3H7B |
23264 |
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 429 |
KBTBD7 |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 430 |
HSP90AA2P |
3324 |
| Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
| 431 |
YAF2 |
|
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 432 |
PASK |
|
| Affinity Capture-Luminescence |
 |
Homo sapiens |
|
| 433 |
HUWE1 |
10075 |
| Affinity Capture-MS |
 |
Homo sapiens |
| Affinity Capture-MS |
 |
Homo sapiens |
|
| 434 |
AR |
367 |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Reconstituted Complex |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| Affinity Capture-Western |
 |
Homo sapiens |
| | | |